RLAY
Relay Therapeutics, Inc. · Healthcare
President and CEO Sanjiv Patel sold $1.7M of Relay Therapeutics, Inc.
Sold$1,711,360
$20.37Price
84,000Shares
−6%Stake
What RLAY did after the filing
- The stock from Thu, Jan 19 close, $20.20
- −15.2%
- S&P 500, same days
- +4.0%
Measured over 30 trading days, to the Mar 3 close.
Traded Tue, Jan 17. Filed Thu, Jan 19, 3:33 PM ET, during the session. Returns use the Jan 19 close and the Mar 3 close. Not investment advice.